![]() ![]() Studies have found that the combination of lopinavir and ritonavir isn't effective. ![]() Researchers are testing the antiviral drugs favipiravir and merimepodib. ![]() Researchers are studying other potential treatments for COVID-19, including: The medication is taken by mouth as a pill. Molnupiravir used to treat mild to moderate COVID-19 in adults at higher risk of serious illness and not able to take other treatments. The FDA has authorized for emergency use another drug called molnupiravir. The medications are taken by mouth as pills. Paxlovid is authorized to treat mild to moderate COVID-19 in people age 12 and older who are at higher risk of serious illness. It helps slow the breakdown of nirmatrelvir. The second drug is an antiviral drug called ritonavir. It blocks the activity of a specific enzyme needed for the virus that causes COVID-19 to replicate. ![]() This drug combines two types of medications in one package. The FDA has authorized for emergency use a drug called Paxlovid. Both medicines may be used in people in the hospital with COVID-19 who are on mechanical ventilators or need supplemental oxygen. It seems to work against COVID-19 by reducing inflammation. Baricitinib is a pill that seems to work against COVID-19 by reducing inflammation and having antiviral activity. The FDA has also approved the rheumatoid arthritis drugs baricitinib (Olumiant) and tocilizumab (Actemra) to treat COVID-19 in some cases. ![]()
0 Comments
Leave a Reply. |